These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24124366)

  • 1. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
    Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
    Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
    Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
    J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
    Kanazaki K; Sano K; Makino A; Shimizu Y; Yamauchi F; Ogawa S; Ding N; Yano T; Temma T; Ono M; Saji H
    Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting.
    Huang J; Wang L; Lin R; Wang AY; Yang L; Kuang M; Qian W; Mao H
    ACS Appl Mater Interfaces; 2013 Jun; 5(11):4632-9. PubMed ID: 23633522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging.
    Lin R; Huang J; Wang L; Li Y; Lipowska M; Wu H; Yang J; Mao H
    Biomater Sci; 2018 May; 6(6):1517-1525. PubMed ID: 29652061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
    Sano K
    Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible polysiloxane-containing diblock copolymer PEO-b-PgammaMPS for coating magnetic nanoparticles.
    Chen H; Wu X; Duan H; Wang YA; Wang L; Zhang M; Mao H
    ACS Appl Mater Interfaces; 2009 Oct; 1(10):2134-40. PubMed ID: 20161520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.
    Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H
    J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with
    Yook S; Cai Z; Jeong JJ; Lu Y; Winnik MA; Pignol JP; Reilly RM
    Mol Pharm; 2020 Apr; 17(4):1226-1236. PubMed ID: 32022567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.
    Yang L; Mao H; Wang YA; Cao Z; Peng X; Wang X; Duan H; Ni C; Yuan Q; Adams G; Smith MQ; Wood WC; Gao X; Nie S
    Small; 2009 Feb; 5(2):235-43. PubMed ID: 19089838
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
    Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
    Tseng SH; Chou MY; Chu IM
    Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.
    Hathaway HJ; Butler KS; Adolphi NL; Lovato DM; Belfon R; Fegan D; Monson TC; Trujillo JE; Tessier TE; Bryant HC; Huber DL; Larson RS; Flynn ER
    Breast Cancer Res; 2011 Nov; 13(5):R108. PubMed ID: 22035507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectability of Her2 positive tumors using monoclonal antibody conjugated iron oxide nanoparticles in MRI.
    Oghabian MA; Jeddi-Tehrani M; Zolfaghari A; Shamsipour F; Khoei S; Amanpour S
    J Nanosci Nanotechnol; 2011 Jun; 11(6):5340-4. PubMed ID: 21770186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency.
    Bruniaux J; Allard-Vannier E; Aubrey N; Lakhrif Z; Ben Djemaa S; Eljack S; Marchais H; Hervé-Aubert K; Chourpa I; David S
    Int J Pharm; 2019 Oct; 569():118572. PubMed ID: 31352052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
    Alric C; Hervé-Aubert K; Aubrey N; Melouk S; Lajoie L; Même W; Même S; Courbebaisse Y; Ignatova AA; Feofanov AV; Chourpa I; Allard-Vannier E
    J Nanobiotechnology; 2018 Feb; 16(1):18. PubMed ID: 29466990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterisation of iron oxide nanoparticles conjugated with epidermal growth factor receptor (EGFR) monoclonal antibody as MRI contrast agent for cancer detection.
    Salehnia Z; Shahbazi-Gahrouei D; Akbarzadeh A; Baradaran B; Farajnia S; Naghibi M
    IET Nanobiotechnol; 2019 Jun; 13(4):400-406. PubMed ID: 31171745
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.